Top Story

Differentiated thyroid carcinoma benefitted from total/near-total thyroidectomy followed by RAI

October 31, 2014

CORONADO, Calif. — A survival benefit was found among patients with differentiated thyroid carcinoma who underwent total/near-total thyroidectomy followed by radioactive iodine therapy, according to study findings presented here.

“To date there are no prospective studies evaluating the longitudinal effects of initial long-term therapy in differentiated thyroid cancer. … The challenge for clinicians becomes balancing the potential risks of more aggressive therapy — such as aggressive thyroid hormone suppression — and the risks associated with long-term thyrotoxicosis with the potential benefits of treatment. This is not always clear, especially in patients who are at a variety of risks for cancer-specific mortality,” Aubrey A. Carhill, MD, of the University of Texas MD Anderson Cancer Center, said during her presentation. “There remains a need for accurate prognostication in order to identify which patients will benefit from different treatment modalities.”

In the Journals

Treatment, biliary drainage improved survival in HCC, obstructive jaundice

October 31, 2014
Chemotherapy, transarterial chemoembolization and successful biliary drainage were effective in improving overall survival among patients with unresectable…
figure Meeting News Coverage

Increased imaging improved early detection in well-differentiated thyroid cancer

October 31, 2014
CORONADO, Calif. — Patients diagnosed with well-differentiated thyroid cancer after 2000 were more likely to exhibit lower risk disease, according to study results…
In the Journals

Weekly prophylaxis with nonacog beta pegol safe, effective for hemophilia B

October 31, 2014
Nonacog beta pegol effectively treated bleeding episodes and was associated with low annualized bleeding rates in patients with hemophilia B, according to study…
More News Headlines »
CME
figure

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Video
figure

CTL019 therapy induced sustained remission in relapsed, refractory ALL

October 30, 2014
PHILADELPHIA — David L. Porter, MD, director of blood and marrow transplantation at Abramson Cancer Center at…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »